Connection
Sarit Polsky to Biosimilar Pharmaceuticals
This is a "connection" page, showing publications Sarit Polsky has written about Biosimilar Pharmaceuticals.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.167 |
|
|
|
-
Thrasher J, Polsky S, Hovsepian L, Nowotny I, Pierre S, Bois De Fer B, Bhargava A, Mukherjee B, Garg SK. Safety and Tolerability of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart (NovoLog) When Used in Insulin Pumps in Adults with Type 1 Diabetes: A Randomized, Open-Label Clinical Trial. Diabetes Technol Ther. 2020 09; 22(9):666-673.
Score: 0.167